
General Technology CQP signs strategic cooperation agreement with Johnson & Johnson Innovation Pharmaceuticals
On October 31st, General Technology CQP signed a strategic cooperation agreement with Johnson & Johnson Innovation Pharmaceuticals. According to the agreement, both parties will fully leverage their platform resources and professional technical advantages, focusing on key aspects of controlled substances channel management, and collaboratively promote the channel management of controlled substances towards higher standards, stricter regulations, and better efficiency, jointly creating a controlled substances supply chain system that is patient-centered while ensuring drug accessibility and safety

